Zhiyun YuXin ZhouZiyi LiuVictor PastranaGomezYu LiuMinzhe GuoLei TianTimothy J NelsonNian WangSeema MitalDavid ChitayatJoseph C WuMarlene RabinovitchSean M WuMichael SnyderYifei MiaoMingxia GuDept of Pediatric,Cincinnati Children's Hosp,Cincinnati,OHStanford Univ,Palo Alto,CACincinnati,OHStanford,CADept of Pediatric,Cincinnati Children's Hosp Med CntrStanford Cardiovascular Institute,Millbrae,CAMAYO CLINIC,Rochester,MNHOSPITAL FOR SICK CHILDREN,Toronto,CanadaSTANFORD UNIV SCH OF MEDICINE,Stanford,CASTANFORD UNIVERSITY SCHOOL MED,Stanford,CASTANFORD UNIVERSITY,Stanford,CAStanford Univ Sch Medicine,Stanford,CA

Abstract:Circulation, Volume 146, Issue Suppl_1, Page A9501-A9501, November 8, 2022. Introduction:Hypoplastic left heart syndrome (HLHS) is a severe form of single ventricle congenital heart disease characterized by the underdeveloped left ventricle. Early serial postmortem examinations revealed a high rate of coronary artery abnormalities in HLHS fetal hearts (e.g., thickened wall and kinking arteries). However, the intrinsic defect in HLHS coronary vessels and its genetic basis remain unclear.Methods:We profiled human fetal heart with an underdeveloped left ventricle (ULV) and induced pluripotent stem cells derived endothelial cells (iPSC-ECs) from HLHS patients at single-cell resolution.CD144+/NPR3-vascular ECs were selected and classified as venous, arterial, and late arterial populations. To study the arterial EC phenotypes, we generated iPSC-arterial ECs (AECs, CDH5+CXCR4+NT5E-/low) derived from 3 HLHS patients and 3 age-matched controls, and evaluated their functionalities including cell cycle regulation, angiogenesis, and inflammatory response.Results:Revealed by single cell RNA-seq and subsequent gene ontology analysis, ULV late arterial EC population showed significant defects in EC development, proliferation, angiogenesis, and Notch signaling compared to the control. Consistently, HLHS iPSCs exhibited impaired AEC differentiation judged by the reduced CXCR4+NT5E-/lowAEC progenitors. Mature HLHS iPSC-AECs showed reduced angiogenesis and enhanced G0/G1 cell cycle arrest with downregulated cell cycle-related genes (e.g.,Ki67, CCND1/2). Healthy human aortic smooth muscle cells exhibited abnormal proliferation and synthetic phenotypes when co-cultured with HLHS iPSC-AECs. Additionally, NOTCH pathway genes (e.g.,DLL4, HEY1, GJA5) were suppressed in both ULV AECs and HLHS iPSC-AECs. HLHSde novovariantKMT2Ddirectly regulated the transcription of NOTCH targeted genes involved in arterial development and proliferation via H3K4me2. Intriguingly, the treatment of NOTCH ligands (Jag1, Dll1) significantly improved the proliferation of HLHS AECs.Conclusions:Our study revealed that HLHS coronary AECs were dysfunctional in angiogenesis, proliferation, and EC-SMC interaction. KMT2D-NOTCH signaling may contribute to the impaired development and proliferation of HLHS AECs.

An Induced Pluripotent Stem Cell Model of Hypoplastic Left Heart Syndrome (HLHS) Reveals Multiple Expression and Functional Differences in HLHS-derived Cardiac Myocytes.

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Abstract 12937: Single-cell Transcriptomic Analysis Reveals Developmentally Impaired Endocardial Population in Hypoplastic Left Heart Syndrome

Abstract 9501: Single-Cell Transcriptomic Analysis and Patient-Specific iPSCs Reveal Dysfunctional Coronary Arterial Endothelial Cells in Hypoplastic Left Heart Syndrome

Common and Divergent Cellular Etiologies Underlying Hypoplastic Left Heart Syndrome and Hypoplastic Right Heart Syndrome

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome

Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome

Generation of an Induced Pluripotent Stem Cell Line (Zjulli003-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYH7/c.4384G > A Mutation

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome.

Hypomorphic NOTCH1 Expression Alters Cardiomyocyte Cellular Architecture in Hypoplastic Left Heart Syndrome

Probing single ventricle heart defects with patient‐derived induced pluripotent stem cells and emerging technologies

Single-Cell RNA Sequencing and Quantitative Proteomics Analysis Elucidate Marker Genes and Molecular Mechanisms in Hypoplastic Left Heart Patients With Heart Failure

Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling

An Induced Pluripotent Stem Cell Line (Ehtjui003-A) Generated From A Neonate With C.1377delc Mutation In The Gene Mybpc3 Causing Hypertrophic Cardiomyopathy

Regenerating the ailing heart: Stem cell therapies for hypoplastic left heart syndrome

In Vivo and In Vitro Approaches to Modeling Hypoplastic Left Heart Syndrome

The complex genetics of hypoplastic left heart syndrome

Deciphering Congenital Heart Disease Using Human Induced Pluripotent Stem Cells